SDHC Promoter Methylation, a Novel Pathogenic Mechanism in Parasympathetic Paragangliomas

Germline mutations in the succinate dehydrogenase A, B, C, and D genes (collectively, SDHx) predispose to the development of paragangliomas (PGLs) arising at the parasympathetic or sympathetic neuroendocrine systems. SDHx mutations cause absence of tumoral immunostaining for SDHB. However, negative...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism 2018-01, Vol.103 (1), p.295-305
Main Authors: Bernardo-Castiñeira, Cristóbal, Valdés, Nuria, Sierra, Marta I, Sáenz-de-Santa-María, Inés, Bayón, Gustavo F, Perez, Raúl F, Fernández, Agustín F, Fraga, Mario F, Astudillo, Aurora, Menéndez, Rafael, Fernández, Belén, del Olmo, Maribel, Suarez, Carlos, Chiara, María-Dolores
Format: Article
Language:English
Subjects:
Copy number
DNA methylation
Hypoxia-inducible factors
Immunohistochemistry
mRNA
Mutation
Neuroendocrine system
Neuroendocrine tumors
Paraganglioma
Parasympathetic nervous system
Phenotypes
Succinate dehydrogenase
Sulfur
Tumorigenesis
VHL protein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Germline mutations in the succinate dehydrogenase A, B, C, and D genes (collectively, SDHx) predispose to the development of paragangliomas (PGLs) arising at the parasympathetic or sympathetic neuroendocrine systems. SDHx mutations cause absence of tumoral immunostaining for SDHB. However, negative SDHB immunostaining has also been found in a subset of PGLs that lack SDHx mutations. Here, we report the comprehensive molecular characterization of one such a tumor of parasympathetic origin compared with healthy paraganglia and other PGLs with or without SDHx mutations. Integration of multiplatform data revealed somatic SDHC methylation and loss of the 1q23.3 region containing the SDHC gene. This correlated with decreased SDHC messenger RNA (mRNA) and protein levels. Furthermore, another genetic event found affected the VHL gene, which showed a decreased DNA copy number, associated with low VHL mRNA levels, and an absence of VHL protein detected by immunohistochemistry. In addition, the tumor displayed a pseudohypoxic phenotype consisting in overexpression of the hypoxia-inducible factor (HIF)-1α and miR-210, as well as downregulation of the iron-sulfur cluster assembly enzyme (ISCU) involved in SDHB maturation. This profile resembles that of SDHx- or VHL-mutated PGLs but not of PGLs with decreased VHL copy number, pointing to SDHC rather than VHL as the pathogenic driver. Collectively, these findings demonstrate the potential importance of both the SDHC epigenomic event and the activation of the HIF-1α/miR-210/ISCU axis in the pathogenesis of SDHx wild-type/SDHB-negative PGLs. To our knowledge, this is the first case of a sporadic parasympathetic PGL that carries silencing of SDHC, fulfilling the two-hit Knudson's model for tumorigenesis.
ISSN:0021-972X
1945-7197
DOI:10.1210/jc.2017-01702